ICON is a global provider of outsourced drug development services to Biopharma, Medical Device, Government, Biosimilar and Generic Organisations.

At ICON, we offer Pharmacovigilance services, with a proven track record of exceptional management of the drug development lifecycle.

Our expert teams are thoroughly experienced in Case-Processing, Database Migrations, Pharmacovigilance Intelligence, EudraVigilance services, End to End Global Safety Reporting, QPPV services, Literature services, Medical Writing, Medical Publishing and Affiliate Management, covering both Clinical Trials and Post-Marketing products.

We offer a complete range of Pharmacovigilance services from virtual Pharmacovigilance departments through to global Pharmacovigilance affiliate management.

Our services are supported by in-depth therapeutic and regulatory expertise, enabled by market-leading technology and analytics. At ICON, our core value is patient safety, which we achieve through a Trusted Partnership with our Clients and a seamless contribution by our team to your Quality Management System.

Our outstanding Pharmacovigilance department includes a dedicated Safety Reporting Compliance and Key Performance Indicator team ensuring continuously excellent and above industry standard inspection outcomes. Our capabilities in global Pharmacovigilance are unique to the industry, with our dedicated Pharmacovigilance Intelligence and Regulatory Change Management teams who will assist you to successfully navigate within an ever changing environment to maintain compliance.